NASDAQ / LIVE COMPANY INTELLIGENCE

ASP Isotopes Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERASPI
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / ASPI COVERAGE

What’s moving ASP Isotopes Inc. now

Current reporting with the operating signal separated from the noise.

01
ASP Isotopes Inc. Announces that a Subsidiary of Renergen Limited Has Entered into its First Take-or-Pay Contract for the Supply of Contained Helium to be Produced at the ...

ASP Isotopes Inc. Announces that a Subsidiary of Renergen Limited Has Entered into its First Take-or-Pay Contract for the Supply of Contained Helium to be Produced at the ...

The development tests whether ASP Isotopes Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
02
ASP Isotopes Inc. (ASPI) Discusses Transition to Commercial Production, Market Expansion, and Critical Materials Platform Transcript

ASP Isotopes Inc. (ASPI) Discusses Transition to Commercial Production, Market Expansion, and Critical Materials Platform Transcript

The development tests whether ASP Isotopes Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
03
ASP Isotopes Inc. and IsoBio, Inc. Announce Series Seed Funding of IsoBio, Inc. to Advance Innovative Antibody-Isotope Conjugates (AICsTM) For Cancer Treatment

ASP Isotopes Inc. and IsoBio, Inc. Announce Series Seed Funding of IsoBio, Inc. to Advance Innovative Antibody-Isotope Conjugates (AICsTM) For Cancer Treatment

The development tests whether ASP Isotopes Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
04
ASP Isotopes Inc. Announces Changes in Boards of ASP Isotopes Inc. and Quantum Leap Energy LLC

ASP Isotopes Inc. Announces Changes in Boards of ASP Isotopes Inc. and Quantum Leap Energy LLC

The story matters when it changes ASP Isotopes Inc.’s customers, execution, competitive position or capital requirements.

Watch next: deployment, backlog, capacity and segment margin.
05
Rosen Law Firm Urges ASP Isotopes Inc. (NASDAQ: ASPI) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Rosen Law Firm Urges ASP Isotopes Inc. (NASDAQ: ASPI) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Investors are testing whether ASP Isotopes Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
06
ASP Isotopes Inc. Provides Update on Plans to Spin-Out its Wholly Owned Subsidiary, Quantum Leap Energy

ASP Isotopes Inc. Provides Update on Plans to Spin-Out its Wholly Owned Subsidiary, Quantum Leap Energy

The story matters when it changes ASP Isotopes Inc.’s customers, execution, competitive position or capital requirements.

Watch next: deployment, backlog, capacity and segment margin.
PRIMARY DOCUMENTS / SEC EDGAR

Latest ASPI filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-20 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-19 · Period 2025-09-30SEC ↗10-K/AAnnual financial reportFiled 2026-04-30 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-30 · Period 2026-07-30SEC ↗8-KMaterial company eventFiled 2026-07-28 · Period 2026-07-28SEC ↗8-KMaterial company eventFiled 2026-07-21 · Period 2026-07-21SEC ↗DEF 14AProxy and shareholder meetingFiled 2025-11-25 · Period 2025-12-08SEC ↗425Official SEC filingFiled 2026-07-22SEC ↗
EARNINGS / QUARTERLY TRACKER

ASP Isotopes Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.